2 min read
The federal government has imposed a ban on the general import of chloroform, limiting its use exclusively to pharmaceutical companies and related sectors. The move comes amid growing concerns over the chemical’s potential health and environmental hazards.
According to an official notification issued by the Ministry of Commerce, amendments have been made to the Import Policy Order 2022 following approval from the Economic Coordination Committee (ECC) of the federal cabinet.
Under the new rules, only companies operating in pharmaceuticals or allied industries can import chloroform. Even then, importation will require a no-objection certificate (NOC) from the Drug Regulatory Authority of Pakistan (DRAP). Authorities emphasized that the step is intended to prevent misuse and ensure tighter control over the chemical’s distribution.
Officials also highlighted the broader safety concerns, noting that chloroform is classified as a substance harmful to human health and the environment, underlining the government’s efforts to minimize risks associated with its use.
Industry experts suggest that the decision may tighten supply chains for chemical distributors but could also encourage stricter compliance and safety standards in pharmaceutical manufacturing.
